Literature DB >> 10903649

Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study.

N J Wald1, M R Law, J K Morris, X Zhou, Y Wong, M E Ward.   

Abstract

OBJECTIVE: To determine whether there is an independent association between infection with Chlamydia pneumoniae and ischaemic heart disease.
DESIGN: Prospective study using a nested case-control design.
SETTING: Medical centre in London run by BUPA, a private medical organisation. PARTICIPANTS: 21 520 professional men aged 35-64 who attended for a medical examination in London between 1975 and 1982. MAIN OUTCOME MEASURE: Death from ischaemic heart disease.
RESULTS: The distributions of concentrations of IgG and IgA antibodies to C pneumoniae were similar in the 647 men who subsequently died of ischaemic heart disease and in 1294 age matched controls who did not. There was no material association with heart disease irrespective of the cut-off point chosen to define seropositivity. At a cut-off point that defines 15% of controls as positive, for example, the odds ratios were 1.26 (95% confidence interval 0.95 to 1.68) for IgG and 1.09 (0.82 to 1.43) for IgA.
CONCLUSIONS: No material association was found between infection with C pneumoniae and ischaemic heart disease. The size and prospective design of the study and the socioeconomic homogeneity of the cohort minimise both random and systematic error.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10903649      PMCID: PMC27436          DOI: 10.1136/bmj.321.7255.204

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  12 in total

1.  Relation of C pneumoniae antibodies to ischaemic heart disease. Finnish study finds significant association between raised IgG, but not IgA, titres and mortality.

Authors:  L von Hertzen; R Isoaho; S L Kivelä; P Saikku
Journal:  BMJ       Date:  1999-12-11

2.  Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; L Ballam; J Morris; B K Butland; P M Sweetnam; P C Elwood
Journal:  BMJ       Date:  1999-04-17

Review 3.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

4.  Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study.

Authors:  N J Wald; M R Law; J K Morris; A M Bagnall
Journal:  BMJ       Date:  1997-11-08

5.  Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not.

Authors:  J M Ossewaarde; E J Feskens; A De Vries; C E Vallinga; D Kromhout
Journal:  Epidemiol Infect       Date:  1998-02       Impact factor: 2.451

6.  Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction.

Authors:  P M Ridker; R B Kundsin; M J Stampfer; S Poulin; C H Hennekens
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

7.  Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease.

Authors:  J Danesh; Y Wong; M Ward; J Muir
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

8.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.

Authors:  P Patel; M A Mendall; D Carrington; D P Strachan; E Leatham; N Molineaux; J Levy; C Blakeston; C A Seymour; A J Camm
Journal:  BMJ       Date:  1995-09-16

9.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

10.  Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland.

Authors:  H Miettinen; S Lehto; P Saikku; S M Haffner; T Rönnemaa; K Pyörälä; M Laakso
Journal:  Eur Heart J       Date:  1996-05       Impact factor: 29.983

View more
  13 in total

1.  Mutagenesis and functional reconstitution of chlamydial major outer membrane proteins: VS4 domains are not required for pore formation but modify channel function.

Authors:  E S Hughes; K M Shaw; R H Ashley
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Heart disease and the inflammatory response.

Authors:  W Koenig
Journal:  BMJ       Date:  2000-07-22

Review 3.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

Review 4.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

5.  Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae.

Authors:  Maria Lucia C Tondella; Deborah F Talkington; Brian P Holloway; Scott F Dowell; Karyn Cowley; Montse Soriano-Gabarro; Mitchell S Elkind; Barry S Fields
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis.

Authors:  J Danesh; P Whincup; M Walker; L Lennon; A Thomson; P Appleby; Y Wong; M Bernardes-Silva; M Ward
Journal:  BMJ       Date:  2000-07-22

7.  Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers.

Authors:  Ali K Adiloglu; Rabia Can; Cem Nazli; Ahmet Ocal; Oktay Ergene; Gulgun Tinaz; Nesimi Kisioglu
Journal:  Tex Heart Inst J       Date:  2005

8.  Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways.

Authors:  H P Jersmann; C S Hii; J V Ferrante; A Ferrante
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 9.  Parachlamydiaceae: potential emerging pathogens.

Authors:  Gilbert Greub; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

10.  Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit.

Authors:  Mika Paldanius; Aini Bloigu; Maija Leinonen; Pekka Saikku
Journal:  Clin Diagn Lab Immunol       Date:  2003-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.